Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Willis Towers Watson plc

1st Jun 2020 12:23

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

 Name of person dealing (Note 1)Barclays PLC.
 Company dealt inWILLIS TOWERS WATSON PLC
 Class of relevant security to which the ORD
 dealings being disclosed relate (Note 2)
 Date of dealing29 May 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD  
 

Long

Short

 

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

 

869,141

0.68%

629,753

0.49%

  

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

601,000

0.47%

395,159

0.31%

  

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

TOTAL:

 

 

 

 

 

1,470,141

1.14%

1,024,912

0.80%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

49

203.7724 USD

Purchase

50

203.4500 USD

Purchase

93

202.9600 USD

Purchase

100

203.4350 USD

Purchase

100

203.0400 USD

Purchase

102

204.2200 USD

Purchase

175

203.2002 USD

Purchase

200

203.9062 USD

Purchase

250

204.6000 USD

Purchase

400

203.7000 USD

Purchase

426

202.9823 USD

Purchase

449

203.2843 USD

Purchase

464

203.0141 USD

Purchase

542

202.9495 USD

Purchase

598

202.9500 USD

Purchase

600

203.3633 USD

Purchase

725

203.1555 USD

Purchase

749

203.8171 USD

Purchase

834

203.3236 USD

Purchase

863

204.5607 USD

Purchase

900

202.9855 USD

Purchase

1,075

203.8553 USD

Purchase

1,100

203.6413 USD

Purchase

1,541

203.5156 USD

Purchase

1,693

203.4793 USD

Purchase

1,737

203.8409 USD

Purchase

2,255

203.6452 USD

Purchase

4,073

203.7224 USD

Purchase

4,591

202.9504 USD

Purchase

5,350

203.7117 USD

Purchase

9,742

203.4712 USD

Purchase

17,754

202.9000 USD

Purchase

22,321

203.0923 USD

Purchase

38,085

203.3379 USD

Purchase

127,105

203.3530 USD

Sale

1

203.1800 USD

Sale

24

205.4700 USD

Sale

25

204.6900 USD

Sale

38

203.1384 USD

Sale

39

202.4900 USD

Sale

50

203.1200 USD

Sale

65

202.9338 USD

Sale

98

205.3400 USD

Sale

100

203.9500 USD

Sale

100

204.9300 USD

Sale

102

203.4384 USD

Sale

167

203.0273 USD

Sale

182

204.0176 USD

Sale

198

203.4765 USD

Sale

342

203.9116 USD

Sale

400

203.4200 USD

Sale

405

203.4825 USD

Sale

695

203.3539 USD

Sale

1,000

202.9980 USD

Sale

1,619

204.4599 USD

Sale

2,297

203.3183 USD

Sale

2,592

203.5992 USD

Sale

3,050

203.5970 USD

Sale

3,672

203.3448 USD

Sale

4,048

203.0089 USD

Sale

5,600

203.2537 USD

Sale

5,697

203.3877 USD

Sale

5,782

203.4136 USD

Sale

5,886

203.3621 USD

Sale

6,150

203.3886 USD

Sale

6,812

203.5439 USD

Sale

7,528

203.3196 USD

Sale

7,550

202.9070 USD

Sale

8,426

203.2756 USD

Sale

8,539

202.9833 USD

Sale

11,337

203.3761 USD

Sale

16,728

203.7018 USD

Sale

34,620

202.9000 USD

Sale

42,551

203.3874 USD

Sale

61,556

203.3651 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

1 Jun 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected 
If a connected EFM, state nature of connection 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200601005428/en/

Copyright Business Wire 2020


Related Shares:

Barclays
FTSE 100 Latest
Value8,875.22
Change0.00